How much is TNE ASX stock?
As of July 2026, Toei Animation has a market capitalization of approximately $3.37 billion USD. This valuation reflects the company's status as a major player in the global animation and media industry, famous for its extensive library of iconic intellectual properties. As a publicly traded company, this market capitalization figure is determined by multiplying its current share price by the total number of outstanding shares and is subject to change based on daily trading activity on the Tokyo Stock Exchange and fluctuations in the JPY to USD exchange rate. Being ranked as a significant entity within the global media landscape, its valuation is closely watched by investors who track the success of its film releases, merchandise licensing, and global distribution deals for its world-renowned anime franchises.
Related FAQs
Techtronic Industries (TTI) owns Milwaukee Tool outright as a wholly-owned subsidiary and flagship professional tool brand within its massive global portfolio.
Toei Animation provides compensation packages that generally align with standard benchmarks across the Japanese anime and commercial entertainment production industry.
Yes, Telix Pharmaceuticals has achieved major regulatory milestones, most notably securing U.S.
Técnicas Reunidas manages occupational health, safety, and environmental protection across its massive international engineering and construction projects by enforcing a rigorous, prevention-first corporate culture.
Telefónica S.A. demonstrates solid and stable operational performance, successfully meeting its overarching financial targets across major European and Latin American core markets.
Sohar International Bank SAOG is a major progressive financial institution headquartered in Muscat, Oman, offering comprehensive corporate banking, retail banking, treasury, and investment services.
TG Therapeutics, Inc. is a fully integrated commercial-stage biopharmaceutical enterprise dedicated to acquiring, developing, and commercializing innovative treatments for B-cell malignancies and autoimmune diseases.
Adtalem Global Education's market capitalization stands at approximately ₹337.88 billion, with the company maintaining significant operational assets totaling around $2.74 billion and cash equivalents of roughly $146.98 million.